chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Muscles are so bad I can't even lift a dish or stretch  arm"; However, about five days later, pain came back on both arms and shoulders, and has been still since beginning of November; next morning after the booster dose, patient woke up with "terrible pain in whole entire body, like a train run over me"; except in her arm, which she couldn't lift up for a few days; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (except in her arm, which she couldn't lift up for a few days), HYPOKINESIA (Muscles are so bad I can't even lift a dish or stretch  arm"), PAIN (next morning after the booster dose, patient woke up with "terrible pain in whole entire body, like a train run over me") and ARTHRALGIA (However, about five days later, pain came back on both arms and shoulders, and has been still since beginning of November) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012F21A, 038A21A and 024M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 18-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 26-Oct-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In October 2021, the patient experienced PAIN IN EXTREMITY (except in her arm, which she couldn't lift up for a few days). On 27-Oct-2021, the patient experienced PAIN (next morning after the booster dose, patient woke up with "terrible pain in whole entire body, like a train run over me"). In November 2021, the patient experienced HYPOKINESIA (Muscles are so bad I can't even lift a dish or stretch  arm") and ARTHRALGIA (However, about five days later, pain came back on both arms and shoulders, and has been still since beginning of November). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) for Adverse event, at an unspecified dose and frequency. On 28-Oct-2021, PAIN (next morning after the booster dose, patient woke up with "terrible pain in whole entire body, like a train run over me") had resolved. At the time of the report, PAIN IN EXTREMITY (except in her arm, which she couldn't lift up for a few days) and ARTHRALGIA (However, about five days later, pain came back on both arms and shoulders, and has been still since beginning of November) had not resolved and HYPOKINESIA (Muscles are so bad I can't even lift a dish or stretch  arm") outcome was unknown.            No concomitant medications were reported   This case was linked to MOD-2021-387389 (Patient Link).
ABOUT 3 MINUTES AFTER RECEIVING COVID-19 MODERNA VACCINE CLIENT EXPERIENCED WHAT IT LOOKED LIKE SEIZURE ACTIVITY. ACCORDING TO MOTHER CLIENT WHO WAS SITTING ON  A CHAIR FOR OBSERVATION POST VACCINATION, DROPPED HIS PHONE TO THE FLOOR AND RAISED BOTH OF HIS ARMS UP WITH PALMS OPENED AND STARTED TO SHAKE A LITTLE WITH EYES CLOSED. MOTHER ASKED FOR HELP. WHEN HELP ARRIAVED CLIENT WAS CONSCIOUS AND NO SEIZING ACTIVITY WAS WITNESS. CLIENT LOOKED PALE AND SWEATY.
Intractable unremitting severe nausea .  I went to see doctor 6/23/2021 to consider if it might be a much delayed vaccine response. She thought the interval was too long, that maybe it was GERD and started me on omeprazole QD but it wasn?t effective until RX BID starting 8/26.
1237 Patient feeling light headed slightly. States she felt something like this after first dose of Moderna. BP 148/82, No other symptoms. HR 77, O2 98%.
eyes irritated /burning; blurred vision; Accidental Exposure; Exposure via eye contact; This case was reported by a pharmacist via call center representative and described the occurrence of eye irritation in a 35-year-old female patient who was administering Herpes zoster (Shingrix) (batch number 3L794, expiry date 21st September 2021)  to the patient for prophylaxis.   On 17th December 2019, the patient received Shingrix. On 17th December 2019, unknown after receiving Shingrix, the patient experienced occupational exposure while administering product and exposure via eye contact. On 18th December 2019, the patient experienced eye irritation and blurred vision. On an unknown date, the outcome of the eye irritation, blurred vision, occupational exposure while administering product and exposure via eye contact were unknown.   It was unknown if the reporter considered the eye irritation and blurred vision to be related to Shingrix.  Additional details were provided as follows: The reporter stated that, while injecting the patient, vaccine slashed into eyes, which led to occupational exposure while administering product, exposure via eye contact. On the day of reporting, the eyes were irritated and burning  and had some blurred vision. The reporter consented to follow up.   Following a correction performed, 'Drug Not Administered' was unchecked.
breathing is not as good since getting the vaccine; eyes itching; face turned red and was hot; Facial swelling; This is a spontaneous report from a contactable consumer (patient). An 80-year-old female patient received first dose of bnt162b2 (Pfizer Covid-19 vaccine, Solution for injection, Batch/lot number: EN9581, Expiration date: Unknown), via an unspecified route in the left arm on 06Feb2021 at 09:00 (age at vaccination: 80-year-old), as a single dose for covid-19 immunization. Medical history included hiatal hernia (ongoing), acid reflux (esophageal), blood pressure high, asthma and from 2016 Lyme's disease (ongoing). She went from Aug until Mar before it was discovered. She had to take repeated doses of Doxycycline. She had 5 bands. She still has 2 bands that are not positive. Her immune system shows that she has positive active Lyme's disease. She has 2 bands that are not active. She goes every 6 months and has the bands checked. She has an upcoming appointment scheduled. Patient was allergic to trees, grass, dirt and mold. Concomitant medications included losartan 25mg twice daily started taking in 2010 or 2011, ongoing for Blood pressure high, fluticasone furoate, vilanterol trifenatate (BREO ELLIPTA) 200mcg 1 puff daily started taking 3-4 years ago ongoing for asthma, fluticasone propionate (PROAIR) 1-2 puffs 4 times daily as needed ongoing from 2020 for asthma, allergy shots 3 injections monthly for allergy has been receiving for over 5 years, ongoing and omeprazole (PRILOSEC) 3 20mg daily for Acid reflux (esophageal) has been using for 10 years or more. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 06Feb2021 (day 804), patient experienced a lot of allergies. After receiving the vaccine her eyes were itching, face turned red and was hot. She also had swelling in her face. Her breathing was ok but she was told to go home and take Benadryl. She took it for 3 days. She has asthma. Her face was red, puffy and hot within 15 minutes after getting the vaccine. She had an appointment already scheduled to get an allergy shot the following week. On 07Feb2021 breathing is not as good since getting the vaccine. She uses nasal sprays and other medications for when her breathing is not good. She is scheduled to get the second dose on 01Mar2021. Her daughter doesn't want her to get it. The patient underwent lab test and procedure which included immune system shows that she has positive active Lyme's disease. The clinical outcome of eyes itching was recovered on 06Feb2021, face turned red and was hot was recovered on 07Feb2021, facial swelling was recovered on 08Feb2021, breathing is not as good since getting the vaccine was not recovered  Follow-up attempts completed. No further information expected.
Patient received Moderna COVID vaccine on 1/28/21 (lot # 042L20A), 2/25/21 (lot # 002A21A), and 1/4/22 (lot # 033H21A). On 9/7/22, patient admitted to our inpatient facility (med/surg unit) with acute respiratory failure with hypoxia (likely combination of COVID-19 infection and probable aspiration pneumonia with recent vomiting episode) and AKI (CKD 3). As of today (9/12/22), patient is still admitted in the med/surg unit.
pt exp a progression of s/sx dx as GBS;pt hosp twice locally a/being sent to another hosp where placed on life support;pt remained on life support until shortly a/Christmas;p/being weaned from ventilator went to rehab for speech, OT & PT
Pseudolymphoma; This spontaneous case was reported by a consumer and describes the occurrence of PSEUDOLYMPHOMA (Pseudolymphoma) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PSEUDOLYMPHOMA (Pseudolymphoma). At the time of the report, PSEUDOLYMPHOMA (Pseudolymphoma) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication were reported  No treatment medication were reported
Patient was administered The bivalent booster as the first dose of the monovalent primary series - vaccine administrator advised that patient did not experience any adverse events at time of administration.
Large erythematous, warm, itchy, macular rash around injection site. Noticed 1 week after injection but believes it was present prior to this.
This spontaneous report as received from a pharmacist refers to a male patient of unknown age. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided. On 30-AUG-2016, the patient was vaccinated by the physician with the first dose of ZOSTAVAX (reported lot# M027117, expiration date: 26-JUL-2017) 0.65 ml, subcutaneously. On 20-SEP-2016, the patient was vaccinated by the pharmacist with the second dose of ZOSTAVAX (reported lot# M027117, expiration date: 26-JUL-2017) 0.65 ml, subcutaneously. No adverse effects were reported. Additional information has been requested.
1 hour following vaccine reported terrible taste in her mouth, sores in her mouth, tender muscles, burning urination and itching.
sore arm, light headed, ringing in head, brain fog, disoriented, low energy
pt exp generalized itching w/o rash;devel redness on chest w/itching;devel red, pinpoint rash w/itching on thighs, abd, chest, neck;tx w/DPH rash/itching resolved x/residual to neck;
Patient felt dizzy.  Vital signs stable.  Given fruit juice.  Patient was stable after 30 minutes.
sore arm after both of her doses of the Moderna Covid-19 Vaccine.; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (sore arm after both of her doses of the Moderna Covid-19 Vaccine.) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (sore arm after both of her doses of the Moderna Covid-19 Vaccine.). At the time of the report, VACCINATION SITE PAIN (sore arm after both of her doses of the Moderna Covid-19 Vaccine.) outcome was unknown.            No relevant concomitant medications were reported. No treatment information was provided.   This case was linked to MOD-2021-358258, MOD-2021-358220 (Patient Link).
About 20-30 minutes after vaccination, patient returned to the pharmacy and reported feeling dizzy/lightheaded and like her heart was racing. Upon checking her BP, it was 175/119 and pulse was 73. Patient stated she had not eaten anything all day before getting vaccination and she sometimes experiences dizziness and chills when she is about to have a migraine episode. Also noted a little bit of pressure in her head. Had patient sit so we could monitor her until EMS arrived.
depression (lasted a long while); left arm felt sore again at the injection site/ left arm pain came back; fatigue; "great pain" in the left arm/ pain in her left leg; bad reaction; weakness; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (bad reaction), ASTHENIA (weakness), DEPRESSION (depression (lasted a long while)), PAIN IN EXTREMITY ("great pain" in the left arm/ pain in her left leg) and VACCINATION SITE PAIN (left arm felt sore again at the injection site/ left arm pain came back) in an 85-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Knee injury. Concurrent medical conditions included Osteoporosis, Asthma (mild (slight cough)) and Allergy (allergic to preservatives like in sweets that causes sneezing and runny nose.).    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 ml. On 27-Feb-2021, the patient experienced VACCINATION COMPLICATION (bad reaction), ASTHENIA (weakness), PAIN IN EXTREMITY ("great pain" in the left arm/ pain in her left leg) and FATIGUE (fatigue). On an unknown date, the patient experienced DEPRESSION (depression (lasted a long while)) and VACCINATION SITE PAIN (left arm felt sore again at the injection site/ left arm pain came back). At the time of the report, VACCINATION COMPLICATION (bad reaction), ASTHENIA (weakness), PAIN IN EXTREMITY ("great pain" in the left arm/ pain in her left leg), VACCINATION SITE PAIN (left arm felt sore again at the injection site/ left arm pain came back) and FATIGUE (fatigue) outcome was unknown and DEPRESSION (depression (lasted a long while)) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient was on unspecified concomitant medications. On an unspecified date patient experienced pain in her left leg that she never experienced before. The outcome for pain in her left leg was unknown. No treatment information was provided.   Reporter did not allow further contact
No adverse effects; expired dose of VAQTA (R022122, 8/9/2019) administered to patient; This spontaneous report has been received from a pharmacist referring to a patient of unknown age and gender. The patient's concurrent conditions, medical history, concomitant therapies and drug allergy or reactions were not reported.            On 14-AUG-2019, the patient was vaccinated with one expired dose of hepatitis a vaccine, inactivated (VAQTA) (lot # R022122, expiration date: 09-AUG-2019; dose and route were not reported) for prophylaxis (expired vaccine used). No adverse effects was reported. No product quality complaint (PQC).
This spontaneous report as received from a physician refers to a 6 days old patient with contraception. The age of the patient was also reported as 5 days. The patient was vaccinated with the first dose of ROTATEQ (lot# unspecified) on 05-NOV-2012. No other co-suspects were reported. No concomitant medications were reported. No adverse symptoms reported. No treatment information was reported. The outcome of the event was unknown. Additional information has been requested.
Injection arm was sore right after injection but I was still able to lift my arm without pain or issue. At around 7pm is when the injection arm started to feel tight and had limited range of motion. At around 10pm is when the pain at the injection arm started to become very painful, with the littlest movements. At 1am the next morning (9/29/2022) I woke up feeling feverish with a fever of 101.9, body aches, joint aches, headache, and chills. I have a slight cough that occurs once in awhile. At 2am, I took 650mg of Tylenol. It did not help.
Started with area at injection site soreness with dark red area aprox. an inch wide with lump. Around 4:30 it I went into the walkin clinic and it measured 3 inches by 3 1/2 inches wide with dark red area, severe pain, and hot. They prescribed clindamycin and to place cold pack, Benadryl, hydrocortisone oimtment. By morning the area grew to about 6 inches with the same symptoms. Went back into the walkin clinic but this time told to continue everything except use heat for 20 min. every 2 hours. This is now the 3rd of Sept at 7:15pm and the site has continued to increase in redness, swelling, heat, and pain. This may not be the final result of this reactions.
whole body weakness; felt like having a flu; migraine; head felt like it is going to explode; arms felt like inflamed; feeling he is going to die; thirsty all the time; felt body was messed up; whole body hurts; headache; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (whole body weakness), INFLUENZA LIKE ILLNESS (felt like having a flu), MIGRAINE (migraine), HEAD DISCOMFORT (head felt like it is going to explode) and PERIPHERAL SWELLING (arms felt like inflamed) in a 37-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032621A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Penicillin allergy.    On 18-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Apr-2021, the patient experienced ASTHENIA (whole body weakness), INFLUENZA LIKE ILLNESS (felt like having a flu), MIGRAINE (migraine), HEAD DISCOMFORT (head felt like it is going to explode), PERIPHERAL SWELLING (arms felt like inflamed), FEELING ABNORMAL (feeling he is going to die), THIRST (thirsty all the time), DISCOMFORT (felt body was messed up), MYALGIA (whole body hurts) and HEADACHE (headache). On 25-Apr-2021, ASTHENIA (whole body weakness), INFLUENZA LIKE ILLNESS (felt like having a flu), MIGRAINE (migraine), HEAD DISCOMFORT (head felt like it is going to explode), PERIPHERAL SWELLING (arms felt like inflamed), FEELING ABNORMAL (feeling he is going to die), THIRST (thirsty all the time), DISCOMFORT (felt body was messed up), MYALGIA (whole body hurts) and HEADACHE (headache) had resolved.            Patient used to take his mental health medications but has stopped 2-3 months from the time reporting.  No concomitant medications reported.  Patient did not take any medication for the symptoms.   This case was linked to MOD-2021-221087 (Patient Link).
Patient was given the influenza virus vaccine.  After administration, a nurse noticed that the patient's parents were not asked about allergies, specifically an egg allergy.  The patient was kept in the exam room for 10 minutes, after which a small welt at the injection site was noted.  The patient was moved to a treatment room for further observation.  Diphenhydramine was administered through the patient's G-tube and ice was applied to the injection site.  Patient rapidly and fully recovered
diagnosed with pneumonia; weakness; dizziness; arm pain; head cold; sinus trouble; Sick; bronchitis; Flu; This case was reported by a consumer via call center representative and described the occurrence of pneumonia in a 74-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included PNEUMOCOCCAL VACCINE (PNEUMONIA VACCINE) for prophylaxis and PERTUSSIS TOXOID (WHOOPING COUGH VACCINE) for prophylaxis.   The patient's past medical history included cold, influenza, bronchitis and pneumonia (experinced before 1984).   In December 2019, the patient received the 1st dose of Shingrix, PNEUMONIA VACCINE and WHOOPING COUGH VACCINE. On an unknown date, less than 3 months after receiving Shingrix, the patient experienced pneumonia (serious criteria GSK medically significant), weakness, dizziness, pain in arm, head cold, sinus disorder, sickness, bronchitis and influenza. On an unknown date, the outcome of the pneumonia, bronchitis and influenza were unknown and the outcome of the weakness, dizziness, pain in arm, head cold and sinus disorder were recovering/resolving and the outcome of the sickness was not recovered/not resolved.   It was unknown if the reporter considered the pneumonia, weakness, dizziness, pain in arm, head cold, sinus disorder, sickness, bronchitis and influenza to be related to Shingrix.  Additional details were provided as follows: The patient had not a cold, flu, bronchitis, or pneumonia since 1984 and she was totally healthy. The patient had a pneumonia vaccine in the beginning of December 2019, Shingrix was administered in mid of December and a whooping cough vaccine was given in late December.  The sinus, head cold, dizziness and weakness presented first. Exact time frame of onset was not known.  The arm pain presented a while after the first symptoms.  The arm was described as a circle or band of pain in both arms above the bicep. The patient had never had a vaccination during that time.  The patient had so sick ever since, diagnosed with pneumonia, with bronchitis, with a head cold, with the flu, on and on, and she did not have any of those. The patient did not start feeling sick until after she had the shingles vaccination. And she stilled sick.  This was three months now. And there appears to be no antidote, plus she supposed to go back and get another one of these shots.
25OCT91 ax temp 103.6; irritability; 26OCT91 ax temp 103.8; vomiting, irritability; 27OCT91 ax temp 103.8; extreme irritability; vomiting;
Throat became slightly tight & voice started to crack within 1 hour of receiving vaccine. Emotional breakdown (crying for no reason) the next night with arm very painful. She slept all day also. Body aches 2 days after vaccine. By the 3rd day at night all symptoms resolved.
Covid-19; Covid-19; This is a spontaneous report received from a contactable reporter(s) (Nurse). The reporter is the patient.  A 63-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 13Mar2021 at 07:00 as dose 1, single (Batch/Lot number: unknown), in right arm, on 03Apr2021 at 07:15 as dose 2, single (Batch/Lot number: unknown), in right arm and on 15Oct2021 at 18:00 as dose 3 (booster), single (Lot number: FH8020) at the age of 63 years, in right arm for covid-19 immunisation. The patient's relevant medical history included: "Colon Cancer", start date: 2016 (unspecified if ongoing); "Chemo" (unspecified if ongoing), notes: Chemo/Radiation Rx; "Chronic reflux" (unspecified if ongoing), notes: Chronic reflux; "Radiation" (unspecified if ongoing), notes: Chemo/Radiation Rx. Concomitant medication(s) included: IMODIUM, start date: 16Apr2017; PRILOSEC [OMEPRAZOLE MAGNESIUM], start date: 01Nov1995; MAGNESIUM CITRATE, start date: 17Apr2017; DIPHENHYDRAMINE, start date: 22May2016; B COMPLEX [VITAMIN B COMPLEX], start date: 15May2016; COQ-10, start date: 01Dec2018. Past drug history included: Compazine, reaction(s): "Drug allergy". The following information was reported: VACCINATION FAILURE(medically significant), COVID-19 (medically significant) all with onset 05May2022 at 06:00, outcome "not recovered" and all described as "Covid-19". Therapeutic measures were taken as a result of vaccination failure, covid-19.  Additional information: If vaccine received: Yes, Other medication in 2weeks: Yes. Other medication in 2weeks product: Patis 30 Fotified Silver Solution, Other medication in 2weeks brand: Patis, Other medication in 2weeks start date: 01Sep2020. Known allergies: Compazine. Other medical history: Colon Cancer 2016/ Chemo/Radiation Rx, Chronic reflux  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.; Sender's Comments: Based on reported information, causal association of event vaccination failure, covid-19 with BNT162b2 cannot be excluded. However, response to vaccine can vary in individuals.
Low grade temp right after vaccinations. 2 days later vomiting and diarrhea started. Fever still. Pt appeared to parents w/weight loss, poor color and crying. Saw MD on 1/14/15 diagnosed with gastroenteritis and given lactobacillus.